|
1
|
Greenlee RT, Hill-Harmon MB, Murray T and
Thun M: Cancer statistics, 2001. CA Cancer J Clin. 51:15–36. 2001.
View Article : Google Scholar
|
|
2
|
Riley PA: Free radicals in biology:
oxidative stress and the effects of ionizing radiation. Int J
Radiat Biol. 65:27–33. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lentine B, Antonucci L, Hunce R, Edwards
J, Marallano V and Krucher NA: Dephosphorylation of threonine-821
of the retinoblastoma tumor suppressor protein (Rb) is required for
apoptosis induced by UV and Cdk inhibition. Cell Cycle.
11:3324–3330. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Choi YJ, Kim YJ, Lee JW, Lee Y, Lim YB and
Chung HW: Cyto-/genotoxic effect of CdSe/ZnS quantum dots in human
lung adenocarcinoma cells for potential photodynamic UV therapy
applications. J Nanosci Nanotechnol. 12:2160–2168. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang J, Zhang L, Liu W, et al: CCDC134
interacts with hADA2a and functions as a regulator of hADA2a in
acetyltransferase activity, DNA damage-induced apoptosis and cell
cycle arrest. Histochem Cell Biol. 138:41–55. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cao C, Lu S, Kivlin R, et al:
AMP-activated protein kinase contributes to UV- and
H2O2-induced apoptosis in human skin
keratinocytes. J Biol Chem. 283:28897–28908. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kyriakis JM and Avruch J: Protein kinase
cascades activated by stress and inflammatory cytokines. Bioessays.
18:567–577. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and
p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Seo M, Cho CH, Lee YI, et al:
Cdc42-dependent mediation of UV-induced p38 activation by G protein
betagamma subunits. J Biol Chem. 279:17366–17375. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kato T Jr, Delhase M, Hoffmann A and Karin
M: CK2 is a C-terminal IkappaB kinase responsible for NF-kappaB
activation during the UV response. Mol Cell. 12:829–839. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Roux PP and Blenis J: ERK and p38
MAPK-activated protein kinases: a family of protein kinases with
diverse biological functions. Microbiol Mol Biol Rev. 68:320–344.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Keller DM, Zeng X, Wang Y, et al: A DNA
damage-induced p53 serine 392 kinase complex contains CK2, hSpt16,
and SSRP1. Mol Cell. 7:283–292. 2001. View Article : Google Scholar
|
|
13
|
Jacks KA and Koch CA: Differential
regulation of mitogen- and stress-activated protein kinase-1 and -2
(MSK1 and MSK2) by CK2 following UV radiation. J Biol Chem.
285:1661–1670. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sayed M, Kim SO, Salh BS, Issinger OG and
Pelech SL: Stress-induced activation of protein kinase CK2 by
direct interaction with p38 mitogen-activated protein kinase. J
Biol Chem. 275:16569–16573. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Scaglioni PP, Yung TM, Cai LF, et al: A
CK2-dependent mechanism for degradation of the PML tumor
suppressor. Cell. 126:269–283. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Landesman-Bollag E, Song DH, Romieu-Mourez
R, et al: Protein kinase CK2: signaling and tumorigenesis in the
mammary gland. Mol Cell Biochem. 227:153–165. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Giroux V, Dagorn JC and Iovanna JL: A
review of kinases implicated in pancreatic cancer. Pancreatology.
9:738–754. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ruzzene M and Pinna LA: Addiction to
protein kinase CK2: a common denominator of diverse cancer cells?
Biochim Biophys Acta. 1804:499–504. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Trembley JH, Wang G, Unger G, Slaton J and
Ahmed K: Protein kinase CK2 in health and disease: CK2: a key
player in cancer biology. Cell Mol Life Sci. 66:1858–1867. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ahmed K, Davis AT, Wang H, et al:
Significance of protein kinase CK2 nuclear signaling in neoplasia.
J Cell Biochem (Suppl). 35:130–135. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Piazza F, Manni S, Ruzzene M, et al:
Protein kinase CK2 in hematologic malignancies: reliance on a
pivotal cell survival regulator by oncogenic signaling pathways.
Leukemia. 26:1174–1179. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pinna LA: Protein kinase CK2: a challenge
to canons. J Cell Sci. 115:3873–3878. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ahmed K, Gerber DA and Cochet C: Joining
the cell survival squad: an emerging role for protein kinase CK2.
Trends Cell Biol. 12:226–230. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Manni S, Brancalion A, Tubi LQ, et al:
Protein kinase CK2 protects multiple myeloma cells from ER
stress-induced apoptosis and from the cytotoxic effect of HSP90
inhibition through regulation of the unfolded protein response.
Clin Cancer Res. 18:1888–1900. 2012. View Article : Google Scholar
|
|
25
|
Pustisek N and Situm M: UV-radiation,
apoptosis and skin. Coll Antropol. 35(Suppl 2): 339–341. 2011.
|
|
26
|
Zandi S, Kalia S and Lui H: UVA1
phototherapy: a concise and practical review. Skin Therapy Lett.
17:1–4. 2012.PubMed/NCBI
|
|
27
|
Tomas D: Apoptosis, UV-radiation,
precancerosis and skin tumors. Acta Med Croatica. 63(Suppl 2):
53–58. 2009.(In Croatian).
|
|
28
|
Lee WR, Shen SC, Lin HY, et al: Wogonin
and fisetin induce apoptosis in human promyeloleukemic cells,
accompanied by a decrease of reactive oxygen species, and
activation of caspase 3 and Ca(2+)-dependent endonuclease. Biochem
Pharmacol. 63:225–236. 2002.PubMed/NCBI
|
|
29
|
Sarno S, Reddy H, Meggio F, et al:
Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP
site-directed inhibitor of protein kinase CK2 (‘casein kinase-2’).
FEBS Lett. 496:44–48. 2001.
|
|
30
|
Bernardi R and Pandolfi PP: Structure,
dynamics and functions of promyelocytic leukaemia nuclear bodies.
Nat Rev Mol Cell Biol. 8:1006–1016. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Scaglioni PP, Yung TM, Choi S, Baldini C,
et al: CK2 mediates phosphorylation and ubiquitin-mediated
degradation of the PML tumor suppressor. Mol Cell Biochem.
316:149–154. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
de Stanchina E, Querido E, Narita M, et
al: PML is a direct p53 target that modulates p53 effector
functions. Mol Cell. 13:523–535. 2004.PubMed/NCBI
|
|
33
|
Lavau C, Marchio A, Fagioli M, et al: The
acute promyelocytic leukaemia-associated PML gene is induced by
interferon. Oncogene. 11:871–876. 1995.PubMed/NCBI
|
